Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Pathog ; 16(12): e1009024, 2020 12.
Article in English | MEDLINE | ID: mdl-33270801

ABSTRACT

Despite the efficacy of antiretroviral-based pre-exposure prophylactics (PrEP) in men who have sex with men, studies in women have produced widely varying outcomes. Recent evidence demonstrates that vaginal microbial communities are associated with increased HIV acquisition risk and may impact PrEP efficacy. Here, we investigate the mechanisms underlying how vaginal bacteria alter PrEP drug levels and impact HIV infection rates ex vivo. Using cervicovaginal lavages (CVLs) from women with or without bacterial vaginosis (BV), we identified microbial metabolism of PrEP drugs in BV samples through LC-MS/MS analysis of soluble drug levels and metabolite formation in dual T-cell cultures. CVL samples were assessed for microbiome analysis using sequencing of bacterial 16S rRNA genes. We also observed non-Lactobacillus bacteria that are associated with BV may potentially impact PrEP efficacy through increased HIV infection rates in co-cultures containing Lactobacillus or BV bacteria, PrEP drugs, CEM-GFP cells, and HIV-1LAI virus. Finally, we used these data to develop a novel predictive mathematical simulation modeling system to predict these drug interactions for future trials. These studies demonstrate how dysbiotic vaginal microbiota may impact PrEP drugs and provides evidence linking vaginal bacteria to PrEP efficacy in women.


Subject(s)
HIV Infections/transmission , Microbiota/physiology , Pre-Exposure Prophylaxis/methods , Vagina/microbiology , Adult , Anti-HIV Agents/therapeutic use , Anti-Retroviral Agents/therapeutic use , Chromatography, Liquid/methods , Dysbiosis/microbiology , Female , HIV Infections/drug therapy , HIV-1/metabolism , HIV-1/pathogenicity , Humans , Microbiota/genetics , RNA, Ribosomal, 16S/genetics , Tandem Mass Spectrometry/methods , Treatment Outcome , Vagina/drug effects , Vaginosis, Bacterial/complications , Vaginosis, Bacterial/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...